AI Verdict
KALV has stronger fundamentals based on our AI analysis.
KALV vs KALU Fundamental Comparison
| Metric | KALV | KALU |
|---|---|---|
| Revenue | $13.7M | $3.4B |
| Net Income | $-158.9M | $112.5M |
| Net Margin | -1,160.0% | 3.3% |
| ROE | -934.8% | 13.6% |
| ROA | -46.7% | 4.4% |
| Current Ratio | 7.22x | 2.95x |
| Debt/Equity | 0.31x | 1.28x |
| EPS | $-2.97 | $6.77 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
KALV vs KALU: Frequently Asked Questions
Is KALV or KALU a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), KALV has stronger fundamentals. KALV is rated HOLD (45% confidence) while KALU is rated SELL (68% confidence). This is not investment advice.
How does KALV compare to KALU fundamentally?
KalVista Pharmaceuticals, Inc. has ROE of -934.8% vs KAISER ALUMINUM CORP's 13.6%. Net margins are -1,160.0% vs 3.3% respectively.
Which stock pays higher dividends, KALV or KALU?
KALV has a dividend yield of N/A or no dividend while KALU has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in KALV or KALU for long term?
For long-term investing, consider that KALV has HOLD rating with 45% confidence, while KALU has SELL rating with 68% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about KALV vs KALU?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For KALV vs KALU, the AI consensus favors KALV based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.